The usual approach to inducing steady-state hyperemia is by use of intravenous adenosine (140 μg/kg/min) administered through a large peripheral vein. Intravenous adenosine activates vascular A2 receptors, leading to predominantly non-endothelium-dependent vasodilation, although there may also be a ...